BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22934964)

  • 1. Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility.
    Bowers RR; Manevich Y; Townsend DM; Tew KD
    Biochemistry; 2012 Oct; 51(39):7740-54. PubMed ID: 22934964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism.
    Kiss B; Duelli A; Radnai L; Kékesi KA; Katona G; Nyitray L
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6048-53. PubMed ID: 22460785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric mode of Ca²⁺-S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling.
    Elliott PR; Irvine AF; Jung HS; Tozawa K; Pastok MW; Picone R; Badyal SK; Basran J; Rudland PS; Barraclough R; Lian LY; Bagshaw CR; Kriajevska M; Barsukov IL
    Structure; 2012 Apr; 20(4):654-66. PubMed ID: 22483112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA.
    Li ZH; Bresnick AR
    Cancer Res; 2006 May; 66(10):5173-80. PubMed ID: 16707441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.
    House RP; Pozzuto M; Patel P; Dulyaninova NG; Li ZH; Zencheck WD; Vitolo MI; Weber DJ; Bresnick AR
    Biochemistry; 2011 Aug; 50(32):6920-32. PubMed ID: 21721535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the S100A4/myosin-IIA complex.
    Ramagopal UA; Dulyaninova NG; Varney KM; Wilder PT; Nallamsetty S; Brenowitz M; Weber DJ; Almo SC; Bresnick AR
    BMC Struct Biol; 2013 Nov; 13():31. PubMed ID: 24252706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
    Hiruta A; Oguri Y; Yokoi A; Matsumoto T; Oda Y; Tomohiro M; Hashimura M; Jiang Z; Tochimoto M; Nakagawa M; Saegusa M
    Am J Pathol; 2020 Nov; 190(11):2304-2316. PubMed ID: 32805233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing Roles of Ca
    Yildirim A; Tekpinar M; Wassenaar TA
    J Phys Chem B; 2021 Sep; 125(36):10059-10071. PubMed ID: 34464144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA.
    Dulyaninova NG; Hite KM; Zencheck WD; Scudiero DA; Almo SC; Shoemaker RH; Bresnick AR
    Biochemistry; 2011 Aug; 50(33):7218-27. PubMed ID: 21749055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A4 downregulates filopodia formation through increased dynamic instability.
    Goh Then Sin C; Hersch N; Rudland PS; Barraclough R; Hoffmann B; Gross SR
    Cell Adh Migr; 2011; 5(5):439-47. PubMed ID: 21975553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma.
    Inukai M; Yokoi A; Ishizuka Y; Hashimura M; Matsumoto T; Oguri Y; Nakagawa M; Ishibashi Y; Ito T; Kumabe T; Saegusa M
    Cell Commun Signal; 2022 Apr; 20(1):46. PubMed ID: 35392912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA.
    Malashkevich VN; Varney KM; Garrett SC; Wilder PT; Knight D; Charpentier TH; Ramagopal UA; Almo SC; Weber DJ; Bresnick AR
    Biochemistry; 2008 May; 47(18):5111-26. PubMed ID: 18410126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenothiazines inhibit S100A4 function by inducing protein oligomerization.
    Malashkevich VN; Dulyaninova NG; Ramagopal UA; Liriano MA; Varney KM; Knight D; Brenowitz M; Weber DJ; Almo SC; Bresnick AR
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8605-10. PubMed ID: 20421509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal region of S100A4 is important for its metastasis-inducing properties.
    Zhang S; Wang G; Liu D; Bao Z; Fernig DG; Rudland PS; Barraclough R
    Oncogene; 2005 Jun; 24(27):4401-11. PubMed ID: 15856021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.
    Du M; Wang G; Ismail TM; Gross S; Fernig DG; Barraclough R; Rudland PS
    J Biol Chem; 2012 May; 287(19):15330-44. PubMed ID: 22399300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.
    Garrett SC; Hodgson L; Rybin A; Toutchkine A; Hahn KM; Lawrence DS; Bresnick AR
    Biochemistry; 2008 Jan; 47(3):986-96. PubMed ID: 18154362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Constrained Helical Peptide Against S100A4 Inhibits Cell Motility in Tumor Cells.
    Naiya G; Kaypee S; Kundu TK; Roy S
    Chem Biol Drug Des; 2015 Oct; 86(4):945-50. PubMed ID: 25763457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
    Chawsheen HA; Jiang H; Ying Q; Ding N; Thapa P; Wei Q
    J Biol Chem; 2019 May; 294(22):8991-9006. PubMed ID: 31000628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms.
    Dulyaninova NG; Ruiz PD; Gamble MJ; Backer JM; Bresnick AR
    Mol Biol Cell; 2018 Mar; 29(5):632-642. PubMed ID: 29282275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
    Park JW; Mieyal JJ; Rhee SG; Chock PB
    J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.